SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation? | Mohan Laboratory

Byrareddy, Siddappa N, and Mahesh Mohan. 2020. “SARS-CoV2 Induced Respiratory Distress: Can Cannabinoids Be Added to Anti-Viral Therapies to Reduce Lung Inflammation?”. Brain, Behavior, and Immunity 87: 120-21.

See also: Cannabinoid modulation of EV composition and function in HIV/SIV infection

Publisher's Version

Last updated on 02/06/2023
PubMed